Picture of TAUNS Laboratories logo

197A TAUNS Laboratories Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M
Source:PROSPECTUSPROSPECTUSYuho
Standards:
JAS
JAS
JAS
Status:FinalFinalFinal
Net Income/Starting Line7,9764,6557,835
Depreciation
Non-Cash Items3,363327399
Unusual Items
Other Non-Cash Items
Changes in Working Capital773-8,7791,025
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities12,679-3,1589,935
Capital Expenditures-2,300-1,166-3,961
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-380-450-149
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2,680-1,615-4,110
Financing Cash Flow Items-1,800-1,900-16.5
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,660-3302,356
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6,339-5,1038,181